Latest filing published 04 May 2022 for Silverback Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jonathan Piazza: trading record in brief
This profile gathers the share dealings of Jonathan Piazza in ARS Pharmaceuticals, Inc., where the filings describe the role as finance chief. Over a trading history stretching from 8 December 2020 to 2 May 2022, the count stands at 3 filings.
Every open-market trade on record is a purchase: 1 purchase worth €206k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants.
The latest filing, published on 4 May 2022, reports a share grant in ARS Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 2,162 days ago, on 8 December 2020. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jonathan Piazza
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 43,691 shares0Common StockSEC:0001209191-22-027162:0
- 11,250 shares0Common StockSEC:0001209191-22-006437:0
2 of 2 declarations
